{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T10:09:26Z","timestamp":1760609366429},"reference-count":32,"publisher":"Japanese Circulation Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2021,7,21]]},"DOI":"10.1253\/circj.cj-20-1269","type":"journal-article","created":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T22:10:08Z","timestamp":1618524608000},"page":"1329-1337","source":"Crossref","is-referenced-by-count":7,"title":["Association Between Atrial High-Rate Episodes and Ischemic\/Major Bleeding Events in Patients With a Cardiac Implantable Electronic Device\u3000\u2015 A 10-Year, Single-Center Historical Cohort Study \u2015"],"prefix":"10.1253","volume":"85","author":[{"given":"Hironori","family":"Ishiguchi","sequence":"first","affiliation":[{"name":"Division of Cardiology, Shimane Prefectural Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ube-Kohsan Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Ishikura","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Shimane Prefectural Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Shimane Prefectural Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Imoto","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Shimane Prefectural Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Sonoyama","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Shimane Prefectural Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Kawabata","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Shimane Prefectural Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Sugamori","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Oda City Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Oki Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Uchida","sequence":"additional","affiliation":[{"name":"Department of Cardiology, National Hospital Organisation Hamada Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsukasa","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Medical Education, Shimane Prefectural Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Morimoto","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology Center for Clinical Research and Education, Hyogo College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Yasuda","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Faculty of Medicine, Shimane University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuaki","family":"Tanabe","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Faculty of Medicine, Shimane University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Yoshiga","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Okamura","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Yano","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Oda","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Shimane Prefectural Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, et al. Worldwide epidemiology of atrial fibrillation: A Global Burden of Disease 2010 Study. <i>Circulation<\/i> 2014; 129: 837\u2013847.","DOI":"10.1161\/CIRCULATIONAHA.113.005119"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Chung MK, Refaat M, Shen WK, Kutyifa V, Cha YM, Di Biase L, et al. Atrial fibrillation: JACC council perspectives. <i>J Am Col Cardiol<\/i> 2020; 75: 1689\u20131713.","DOI":"10.1016\/j.jacc.2020.02.025"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. <i>Eur Heart J<\/i> 2016; 37: 2893\u20132962.","DOI":"10.15829\/1560-4071-2017-7-7-86"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, et al. Subclinical atrial fibrillation and the risk of stroke. <i>N Engl J Med<\/i> 2012; 366: 120\u2013129.","DOI":"10.1056\/NEJMoa1105575"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Boriani G, Glotzer TV, Santini M, West TM, De Melis M, Sepsi M, et al. Device-detected atrial fibrillation and risk for stroke: An analysis of &gt;10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices). <i>Eur Heart J<\/i> 2014; 35: 508\u2013516.","DOI":"10.1093\/eurheartj\/eht491"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Glotzer TV, Daoud EG, Wyse DG, Singer DE, Ezekowitz MD, Hilker C, et al. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: The TRENDS study. <i>Circ Arrhythm Electrophysiol<\/i> 2009; 2: 474\u2013480.","DOI":"10.1161\/CIRCEP.109.849638"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Capucci A, Santini M, Padeletti L, Gulizia M, Botto G, Boriani G, et al. Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. <i>J Am Coll Caridol<\/i> 2005; 46: 1913\u20131920.","DOI":"10.1016\/j.jacc.2005.07.044"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Van Gelder IC, Healey JS, Crijns HJGM, Wang J, Hohnloser SH, Gold MR, et al. Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT. <i>Eur Heart J<\/i> 2017; 38: 1339\u20131344.","DOI":"10.1093\/eurheartj\/ehx042"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Gallego P, Rold\u00e1n V, Torregrosa JM, G\u00e1lvez J, Vald\u00e9s M, Vicente V, et al. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation. <i>Circ Arrhythm Electrophysiol<\/i> 2012; 5: 312\u2013318.","DOI":"10.1161\/CIRCEP.111.967000"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Lip GY, Wang KL, Chiang CE. Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: Time for a reappraisal. <i>Int J Cardiol<\/i> 2015; 180: 246\u2013254.","DOI":"10.1016\/j.ijcard.2014.11.182"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Suzuki S, Yamashita T, Kato T, Fujino T, Sagara K, Sawada H, et al. Incidence of major bleeding complication of warfarin therapy in Japanese patients with atrial fibrillation. <i>Circ J<\/i> 2007; 71: 761\u2013765.","DOI":"10.1253\/circj.71.761"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ishiguchi H, Ishikura M, Yoshida M, Imoto K, Sonoyama K, Kawabata T, et al. Incidence and risk factors for cardiac implantable electronic device infection in current clinical settings in a Japanese population: A 20-year single-center observational study. <i>J Cardiol<\/i> 2020; 76: 115\u2013122.","DOI":"10.1016\/j.jjcc.2020.01.006"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Miyazawa K, Pastori D, Li YG, Sz\u00e9kely O, Shahid F, Boriani G, et al. Atrial high rate episodes in patients with cardiac implantable electronic devices: Implications for clinical outcomes. <i>Clin Res Cardiol<\/i> 2019; 108: 1034\u20131041.","DOI":"10.1007\/s00392-019-01432-y"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. JCS Joint Working Group. Guidelines for pharmacotherapy of atrial fibrillation (JCS 2008): Digest version. <i>Circ J<\/i> 2010; 74: 2479\u20132500.","DOI":"10.1253\/circj.CJ-88-0001"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, et al. Standardized bleeding definitions for cardiovascular clinical trials: A consensus report from the bleeding academic research consortium. <i>Circulation<\/i> 2011; 123: 2736\u20132747.","DOI":"10.1161\/CIRCULATIONAHA.110.009449"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation. <i>JAMA<\/i> 2001; 285: 2864\u20132870.","DOI":"10.1001\/jama.285.22.2864"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The Euro heart survey on atrial fibrillation. <i>Chest<\/i> 2010; 137: 263\u2013272.","DOI":"10.1378\/chest.09-1584"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The Euro Heart Survey. <i>Chest<\/i> 2010; 138: 1093\u20131100.","DOI":"10.1378\/chest.10-0134"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kawakami H, Nagai T, Saito M, Inaba S, Seike F, Nishimura K, et al. Clinical significance of atrial high-rate episodes for thromboembolic events in Japanese population. <i>Heart Asia<\/i> 2017; 9: 1\u20136.","DOI":"10.1136\/heartasia-2017-010954"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Nakano M, Kondo Y, Nakano M, Kajiyama T, Hayashi T, Ito R, et al. Impact of atrial high-rate episodes on the risk of future stroke. <i>J Cardiol<\/i> 2019; 74: 144\u2013149.","DOI":"10.1016\/j.jjcc.2019.01.006"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Takabayashi K, Hamatani Y, Yamashita Y, Takagi D, Unoki T, Ishii M, et al. Incidence of stroke or systemic embolism in paroxysmal versus sustained atrial fibrillation: The Fushimi Atrial Fibrillation Registry. <i>Stroke<\/i> 2015; 46: 3354\u20133361.","DOI":"10.1161\/STROKEAHA.115.010947"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Oagawa H, An Y, Ikeda S, Aono Y, Doi K, Ishii M, et al. Progression from paroxysmal to sustained atrial fibrillation is associated with increased adverse events. <i>Stroke<\/i> 2018; 49: 2301\u20132308.","DOI":"10.1161\/STROKEAHA.118.021396"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Okumura K, Tomita H, Nakai M, Kodani E, Akao M, Suzuki S, et al. Risk factors associated with ischemic stroke in Japanese patients with nonvalvular atrial fibrillation. <i>JAMA Netw Open<\/i> 2020; 3: e202881.","DOI":"10.1001\/jamanetworkopen.2020.2881"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Steinberg BA, Hellkamp AS, Lokhnygina Y, Patel MR, Breithardt G, Hankey GJ, et al. Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: Results from the ROCKET-AF Trial. <i>Eur Heart J<\/i> 2015; 36: 281\u2013288.","DOI":"10.1093\/eurheartj\/ehu359"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Yamashita Y, Hamatani Y, Esato M, Chun YH, Tsuji H, Wada H, et al. Clinical characteristics and outcomes in extreme elderly (age \u226585 years) Japanese patients with atrial fibrillation: The Fushimi AF Registry. <i>Chest<\/i> 2016; 149: 401\u2013412.","DOI":"10.1378\/chest.15-1095"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Kitazono T, Ikeda T, Ogawa S, Nakagawara J, Minematsu K, Miyamoto S, et al. Real-world outcomes of rivaroxaban treatment in elderly Japanese patients with nonvalvular atrial fibrillation. <i>Heart Vessels<\/i> 2020; 35: 399\u2013408.","DOI":"10.1007\/s00380-019-01487-x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Murata N, Okumura Y, Yokoyama K, Matsumoto N, Tachibana E, Kuronuma K, et al. Clinical outcomes of off-label dosing of direct oral anticoagulant therapy among Japanese patients with atrial fibrillation identified from the SAKURA AF Registry. <i>Circ J<\/i> 2019; 83: 727\u2013735.","DOI":"10.1253\/circj.CJ-18-0991"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Okumura K, Akao M, Yoshida T, Kawata M, Okazaki O, Akashi S, et al. Low-dose edoxaban in very elderly patients with atrial fibrillation. <i>N Engl J Med<\/i> 2020; 383: 1735\u20131745.","DOI":"10.1056\/NEJMoa2012883"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Perino AC, Fan J, Askari M, Heidenreich PA, Keung E, Raitt MH, et al. Practice variation in anticoagulation prescription and outcomes after device-detected atrial fibrillation. <i>Circulation<\/i> 2019; 139: 2502\u20132512.","DOI":"10.1161\/CIRCULATIONAHA.118.038988"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Hindriks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstr\u00f6m-Lundqvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). <i>Eur Heart J<\/i> 2021; 42: 373\u2013498.","DOI":"10.1093\/eurheartj\/ehaa612"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Daoud EG, Glotzer TV, Wyse DG, Ezekowitz MD, Hilker C, Koehler J, et al. Temporal relationship of atrial arrhythmias, cerebrovascular events, and systemic emboli based on stored device data: A subgroup analysis of TRENDS. <i>Heart Rhythm<\/i> 2011; 8: 1416\u20131423.","DOI":"10.1016\/j.hrthm.2011.04.022"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Martin DT, Bersohn MM, Waldo AL, Wathen MS, Choucair WK, Lip GY, et al. Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices. <i>Eur Heart J<\/i> 2015; 36: 1660\u20131668.","DOI":"10.1093\/eurheartj\/ehv115"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/85\/8\/85_CJ-20-1269\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T03:17:18Z","timestamp":1627096638000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/85\/8\/85_CJ-20-1269\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,21]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-20-1269","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,21]]},"article-number":"CJ-20-1269"}}